beta-Lactamase Inhibitors

All categories
DBCAT001119Therapeutic categoryJ01CG

Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. A DrugBank category of 13 drugs. 9 of them are approved.

ATC classification
Also known as
Antagonists, beta Lactamase · beta Lactamase Antagonists · beta Lactamase Inhibitors · Inhibitors, beta Lactamase · Inhibitors, beta-Lactamase
Drugs

What you can answer from here — as of August 24, 2016

13DrugsEach linked to its full drug card
Listed above
25Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,338Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
9Routes of administrationHow the drugs in this class are given
Sign in
1SubcategoryNarrower classes within this one
Sign in

Which targets do beta-Lactamase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In